Table 1.
Pathology | Quantity | Percentage |
---|---|---|
Benign lesions | 5 | |
Thymic hyperplasia | 2 | 40% |
Mature teratoma | 2 | 40% |
Castleman disease | 1 | 20% |
Malignant lesions | 50 | |
Low-risk thymoma | 13 | 26% |
High-risk thymoma | 16 | 32% |
Thymic carcinoma | 8 | 16% |
Thymic NET | 2 | 4% |
Malignant GCT | 4 | 8% |
Lymphoma | 7 | 14% |
NET, Neuroendocrine tumor; GCT, Germ cell tumor.Bold and italics values indicated the values of the two main groups (benign lesions and malignant lesions).